1-196907017-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001201550.3(CFHR4):c.596C>T(p.Ser199Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000139 in 1,610,626 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S199Y) has been classified as Uncertain significance.
Frequency
Consequence
NM_001201550.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFHR4 | NM_001201550.3 | c.596C>T | p.Ser199Phe | missense_variant | 4/10 | ENST00000608469.6 | NP_001188479.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFHR4 | ENST00000608469.6 | c.596C>T | p.Ser199Phe | missense_variant | 4/10 | 1 | NM_001201550.3 | ENSP00000477162.2 |
Frequencies
GnomAD3 genomes AF: 0.000106 AC: 16AN: 151196Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000340 AC: 84AN: 247060Hom.: 1 AF XY: 0.000284 AC XY: 38AN XY: 133986
GnomAD4 exome AF: 0.000143 AC: 208AN: 1459430Hom.: 5 Cov.: 31 AF XY: 0.000128 AC XY: 93AN XY: 725884
GnomAD4 genome AF: 0.000106 AC: 16AN: 151196Hom.: 0 Cov.: 32 AF XY: 0.000122 AC XY: 9AN XY: 73808
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 12, 2021 | The c.596C>T (p.S199F) alteration is located in exon 4 (coding exon 4) of the CFHR4 gene. This alteration results from a C to T substitution at nucleotide position 596, causing the serine (S) at amino acid position 199 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | CFHR4 NM_001201550.2 exon 4 p.Ser199Phe (c.596C>T): This variant has not been reported in the literature but is present in 0.6% (65/10304) of Ashkenazi Jewish alleles in the Genome Aggregation Database (https://gnomad.broadinstitute.org/variant/1-196876147-C-T?dataset=gnomad_r2_1). Evolutionary conservation for this variant is limited or unavailable; computational predictive tools for this variant are unclear. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at